Aerpio Pharmaceuticals to Report Second Quarter 2020 Financial Results on August 12
CINCINNATI, Aug. 10, 2020 (GLOBE NEWSWIRE) — Aerpio Pharmaceuticals, Inc. (“Aerpio”) (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds […]
Rubius Therapeutics Reports Second Quarter 2020 Financial Results and Positive Progress Across Pipeline
Strong Momentum in Dosing Patients and Manufacturing Clinical Supply for RTX-240 Phase 1/2 Solid Tumor Clinical TrialInvestigational New Drug Application on […]
ShotSpotter to Present at Canaccord Genuity’s 40th Annual Growth Conference on August 12, 2020 at 9:30 a.m. ET
NEWARK, Calif., Aug. 10, 2020 (GLOBE NEWSWIRE) — ShotSpotter, Inc. (NASDAQ: SSTI), the leader in acoustic gunshot detection and precision […]
TORM plc to announce second quarter and first half 2020 results
TORM plc (“TORM” or the “Company”) (ticker: TRMD A on Nasdaq in Copenhagen and TRMD on Nasdaq in New York) […]
Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2020, and Provides Business Update
NORCROSS, Ga., Aug. 10, 2020 (GLOBE NEWSWIRE) — Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target […]
Cellectar Reports Second Quarter 2020 Financial Results and Provides a Corporate Update
FLORHAM PARK, N.J., Aug. 10, 2020 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a clinical-stage biopharmaceutical company focused on the […]
Krystal Biotech Reports Second Quarter 2020 Financial Results and Provides Update on Operational Progress
Initiated the pivotal GEM-3 clinical study evaluating B-VEC in DEB patients Today announced enrollment of 1st patient in Phase 2 clinical […]
Enphase Energy Powers Commercial Business for REAL Solar of Minneapolis
FREMONT, Calif., Aug. 10, 2020 (GLOBE NEWSWIRE) — Enphase Energy, Inc. (NASDAQ:ENPH), a global energy technology company and the world’s […]
Ovid Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update
Announces completion of enrollment in the pivotal Phase 3 NEPTUNE trial with OV101 in Angelman syndrome; topline results expected in […]
CUMULUS MEDIA Reports Operating Results for the Second Quarter 2020 and Announces Definitive Agreement to Monetize Tower Portfolio for $213 Million
ATLANTA, Aug. 10, 2020 (GLOBE NEWSWIRE) — Cumulus Media Inc. (NASDAQ: CMLS) (the “Company,” “CUMULUS MEDIA,” “we,” “us,” or “our”) […]
